Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Fujisawa describes orally active cephalosporin

Oct. 4, 1996

Hydroxypyridone cephalosporins described by Kyorin

Oct. 4, 1996

Takeda discloses cephem antibacterial compounds

Oct. 4, 1996

Sankyo discloses anthelmintic agents

Sep. 27, 1996

New antiinfluenza virus agent reported by Gilead Sciences

Sep. 27, 1996

Topical Reticulose reported to be effective against HPV

Sep. 27, 1996

Efficacy and safety of antisense compound for CMV retinitis confirmed

Sep. 27, 1996

Lilly's newest antipicornavirus agents

Sep. 27, 1996

Positive phase III results with AmBisome to be included in NDA filing

Sep. 27, 1996

High clinical efficacy reported for Penederm's Mentax antifungal product

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...